https://www.pharmaglobenewswire.com/the-global-herbal-medicine-market-was-valued-at-usd-71445-63-million-in-2024-growing-at-a-cagr-of-10-18-to-reach-usd-154072-10-million-by-2032-estimates-delveinsight/Pharma Globenewswireen2026-07-16T12:42:32+01:00The Global Herbal Medicine Market was valued at USD 71,445.63 million in 2024, growing at a CAGR of 10.18% to reach USD 154,072.10 million by 2032, estimates DelveInsight https://www.pharmaglobenewswire.com/liquid-biopsy-in-cancer-diagnostics-market-set-to-witness-significant-growth-driven-by-rising-cancer-burden-genomic-innovation-and-expanding-clinical-adoption-through-2034/Pharma Globenewswireen2026-07-16T11:57:42+01:00Liquid Biopsy in Cancer Diagnostics Market Set to Witness Significant Growth Driven by Rising Cancer Burden, Genomic Innovation, and Expanding Clinical Adoption Through 2034 https://www.pharmaglobenewswire.com/nanomedicine-market-to-reach-usd-507-billion-by-2032-driven-by-targeted-drug-delivery-innovations-and-expanding-precision-medicine-applications/Pharma Globenewswireen2026-07-15T10:37:56+01:00Nanomedicine Market to Reach USD 507 Billion by 2032, Driven by Targeted Drug Delivery Innovations and Expanding Precision Medicine Applications https://www.pharmaglobenewswire.com/osteosarcoma-market-significant-growth-driven-by-innovation-and-emerging-therapies-delveinsight-2/Pharma Globenewswireen2026-07-15T10:36:24+01:00Osteosarcoma Market: Significant Growth Driven by Innovation and Emerging Therapies – DelveInsight https://www.pharmaglobenewswire.com/chronic-myeloid-leukemia-pipeline-2026-clinical-trials-landscape-with-moa-and-roa-highlights-by-delveinsight/Pharma Globenewswireen2026-07-15T09:02:40+01:00Chronic Myeloid Leukemia Pipeline 2026: Clinical Trials Landscape with MOA and ROA Highlights by DelveInsight